JS

Jose Saldanha

BM Biogen Idec Ma: 11 patents #10 of 270Top 4%
PL Prothena Biosciences Limited: 11 patents #5 of 46Top 15%
Pfizer: 10 patents #490 of 5,153Top 10%
Johnson & Johnson: 4 patents #2,223 of 7,810Top 30%
NA Novartis Ag: 4 patents #1,111 of 5,128Top 25%
EP Elan Pharmaceuticals: 3 patents #86 of 269Top 35%
TB Tanox Biosystems: 3 patents #7 of 14Top 50%
CP Chugai Pharmaceutical: 3 patents #322 of 1,238Top 30%
NL Neuralab Limited: 2 patents #2 of 5Top 40%
BM Biogen Ma: 2 patents #138 of 400Top 35%
CY Cytel: 2 patents #23 of 56Top 45%
EI Elan Pharma International: 2 patents #29 of 111Top 30%
MP Millennium Pharmaceuticals: 2 patents #358 of 771Top 50%
NL Neotope Biosciences Limited: 2 patents #8 of 11Top 75%
SR Sloan Kettering Institute For Cancer Research: 2 patents #196 of 644Top 35%
UT University Of Tennessee: 1 patents #417 of 1,053Top 40%
BO BOE: 1 patents #7,844 of 12,373Top 65%
AN Athena Neurosciences: 1 patents #49 of 81Top 65%
Merck: 1 patents #5,419 of 9,382Top 60%
II Imclone Systems Incorporated: 1 patents #9 of 30Top 30%
Overall (All Time): #41,813 of 4,157,543Top 2%
58
Patents All Time

Issued Patents All Time

Showing 1–25 of 58 patents

Patent #TitleCo-InventorsDate
11345749 Humanized antibodies that recognize alpha-synuclein Tarlochan S. Nijjar 2022-05-31
10875909 Humanized antibodies that recognize alpha-synuclein Tarlochan S. Nijjar 2020-12-29
10723792 Humanized antibodies that recognize alpha-synuclein Tarlochan S. Nijjar 2020-07-28
10597441 Humanized antibodies that recognize alpha-synuclein Tarlochan S. Nijjar 2020-03-24
10450369 Humanized antibodies that recognize alpha-synuclein Tarlochan S. Nijjar 2019-10-22
10336826 Antibodies to VLA-1 Michael Karpusas, Paul Lyne, Ellen A. Garber Stark 2019-07-02
10118960 Humanized antibodies that recognize alpha-synuclein Tarlochan S. Nijjar 2018-11-06
9884906 Humanized antibodies that recognize alpha-synuclein Tarlochan S. Nijjar 2018-02-06
9670273 Humanized antibodies that recognize alpha-synuclein Tarlochan S. Nijjar 2017-06-06
9644030 Antibodies to VLA-1 Michael Karpusas, Paul Lyne, Ellen A. Garber Stark 2017-05-09
9556259 Humanized antibodies that recognize alpha-synuclein Tarlochan S. Nijjar 2017-01-31
9234031 Humanized antibodies that recognize alpha-synuclein Tarlochan S. Nijjar 2016-01-12
9217030 Humanized antibodies that recognize alpha-synuclein Tarlochan S. Nijjar 2015-12-22
9205157 Anti ganglioside GD3 antibodies and uses thereof Paul Chapman, Lisa Davidson 2015-12-08
9051363 Humanized antibodies that recognize beta amyloid peptide Guriq Basi, Dale B. Schenk 2015-06-09
8992924 Anti-ανβ6 antibodies and uses thereof Shelia M. Violette, Louise A. Koopman, Kenneth J. Simon, Paul H. Weinreb, Herman Van Vlijmen +1 more 2015-03-31
8791243 Treatment and prophylaxis of amyloidosis Dale B. Schenk, Peter A. Seubert, Jonathan S. Wall 2014-07-29
8790644 Humanized antibodies that recognize alpha-synuclein Tarlochan S. Nijjar 2014-07-29
8609820 Humanized antibodies that recognize alpha-synuclein Tarlochan S. Nijjar 2013-12-17
8519112 Humanized antibodies against monocyte chemotactic proteins Antonin de Fougerolles, Victor Kotelianski, Ellen Garber, Carl Reid, Herman Van Vlijmen 2013-08-27
8268973 Anti-amyloid antibodies Dale B. Schenk, Peter A. Seubert 2012-09-18
8246958 Methods of inhibiting alpha-4-dependent interactions with VCAM-1 with anti-VLA-4 antibodies Mary M. Bendig, Olivier Leger, Tarran Jones, Ted Yednock 2012-08-21
8221752 Antibodies against human interleukin-13 and uses therefor Marion T. Kasaian, Lioudmila Tchistiakova, Geertruida M. Veldman, Kimberly Ann Marquette, Xiang-Yang Tan +10 more 2012-07-17
8207308 Anti ganglioside GD3 antibodies and uses thereof Paul Chapman, Lisa Davidson 2012-06-26
8128928 Humanized antibodies that recognize beta amyloid peptide Guriq Basi 2012-03-06